Cannabis consumption improves liver condition

Dr. Christopher Smith
3 min readOct 18, 2021

--

Remember, I promote CBD and not habit forming THC. And, I rely on only high quality CBD from recognized sources, such as https://www.buy-swiss-cbd-ihs.com/redir-affiliation-186-79026.html who sell pure Swiss products.

Early preclinical and epidemiological research suggests that cannabis may potentially treat various forms of liver disease. Causes of liver disease are widespread, including drugs and alcohol, hepatitis A-E, non-alcoholic fatty liver disease, and hemochromatosis. When the liver is repeatedly damaged, scar tissue replaces healthy liver cells in a process called fibrosis. This scar tissue does not perform any function, further distorting the liver’s internal structure, and interfering with blood flow to and from the liver. It may even cause liver pain. Eventually, this lack of blood flow kills more liver cells and the result is a continuous cycle of liver scarring.

Research suggests that cannabis https://www.buy-swiss-cbd-ihs.com/redir-affiliation-186-79026.html may have anti-fibrogenic properties. Consequently, in epidemiological studies, cannabis consumers have a lower prevalence of liver disease progression than their peers. There is potential of cannabis to effectively treat liver disease, like it treats pain, nausea, and so many other conditions.

CBD and Hepatic Stellate Cell Death

Basically, the cellular mechanisms at work for the development of liver fibrosis chiefly involve specialized cells called hepatic stellate cells (HSC).[1] HSCs play a critical role in the initiation, progression, and regression of liver fibrosis, by secreting fibrogenic factors that encourage other cells to produce collagen and corresponding scar tissue.

In a study published in Cell Death and Disease (2011), researchers found that CBD could activate and kill HSCs.[2]

Fibrosis Regression Following Chronic CB2 Receptor Activation

In a study published in the Journal of Pharmacology and Experimental Therapeutics (2007), researchers chronically activated hepatic CB2 receptors in cirrhotic rats by treating them with a CB2 receptor agonist (CBD is a top agonist for CB2 receptors https://www.buy-swiss-cbd-ihs.com/redir-affiliation-186-79026.html) daily, for a total of nine days. [3]

RELATED Endocannabinoid Receptors and How They Work In Your Body

Further studies will explore how these findings relate to naturally occurring cannabinoids like THC and CBD, but it is clear that an association exists between endocannabinoid system activation and a reduction in hepatic fibrosis. Although clinical trials have not been conducted yet, there is some research to suggest that this may be the case in humans.

Reduced Liver Disease and Pain for Cannabis Consumers?

In a study published in Liver International (2018)[4] analysis of over 300,000 records showed that among alcohol users, dependent and non-dependent cannabis consumers had significantly lower odds of developing alcoholic steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma.

For Swiss CBD try https://www.buy-swiss-cbd-ihs.com/redir-affiliation-186-79026.html

Do Cannabis Consumers Have Less Liver Disease and Pain?

A similar study published in PLoS One (2017) of six million patients, cannabis consumers had a significantly lower prevalence of non-alcoholic fatty liver disease compared to non-consumers.

In a study published in the Canadian Journal of Gastroenterology and Hepatology (2018), the researchers found that cannabis-consuming Hepatitis C virus patients were less likely to develop liver disease and had lower healthcare costs than non-consumers, comparatively. [6]

Summary

Medical use of CBD should be after consulting a physician and you should rely on high quality Swiss CBD from https://www.buy-swiss-cbd-ihs.com/redir-affiliation-186-79026.html and not sources with unwanted chemicals.

--

--

Dr. Christopher Smith
Dr. Christopher Smith

Written by Dr. Christopher Smith

Physician, scientist, professor, studying role of CBD in epilepsy, Parkinson’s, multiple sclerosis, dystonia, anxiety, and cancers.

No responses yet